BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4173476)

  • 1. [Studie on estrogenic and anti-estrogenic activities of various synthetic progestins].
    Mizoguchi S
    Nihon Naibunpi Gakkai Zasshi; 1967 Dec; 43(9):842-57. PubMed ID: 4173476
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-estrogenic and anti-androgenic effects of certain oral gestagens].
    Hecht-Lucari G
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):620-3. PubMed ID: 4160664
    [No Abstract]   [Full Text] [Related]  

  • 3. The sialic acid content in mouse female reproductive organs as a quantitative parameter for testing the estrogenic and antiestrogenic effect, antiestrogenic depot effect, and dissociated effect of estrogens on the uterus and vagina.
    Nishino Y; Neumann F
    Acta Endocrinol Suppl (Copenh); 1974; 187():3-62. PubMed ID: 4134905
    [No Abstract]   [Full Text] [Related]  

  • 4. Early regression of the progestational response in rabbits after administration of progestins in the estrogen priming phase.
    Black LJ
    Fertil Steril; 1974 Jul; 25(7):575-85. PubMed ID: 4135327
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioautographic study of the effect of estradiol-17 , estrone, estriol, progesterone, testosterone and corticosterone on the in vitro uptake of 2,4,6,7- 3 H estradiol-17 by uterine eosinophils of the rat.
    Tchernitchin A
    Steroids; 1972 Apr; 19(4):575-86. PubMed ID: 5028883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of steroid hormones on the proliferation of HeLa cells].
    Kono K
    Igaku Kenkyu; 1971 Apr; 41(4):279-312. PubMed ID: 4256814
    [No Abstract]   [Full Text] [Related]  

  • 7. Formation of estrogen nuclear receptor in uterus: effect of androgens, estrone and nafoxidine.
    Rochefort H; Lignon F; Capony F
    Biochem Biophys Res Commun; 1972 May; 47(4):662-70. PubMed ID: 4260313
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of various anti-oestrogenic compounds on the reticulo-endothelial system and reproductive tract in the ovariectomized mouse.
    Nicol T; Vernon-Roberts B; Quantock DC
    J Endocrinol; 1966 Mar; 34(3):377-86. PubMed ID: 5931915
    [No Abstract]   [Full Text] [Related]  

  • 9. The binding affinity and specificity of the estrogen receptor of the rat uterus and anterior pituitary.
    Notides AC
    Endocrinology; 1970 Nov; 87(5):987-92. PubMed ID: 5482943
    [No Abstract]   [Full Text] [Related]  

  • 10. The limitations of using mouse uterine weight as an assay of oestrogen antagonism.
    Lee AE
    Acta Endocrinol (Copenh); 1971 Jun; 67(2):345-52. PubMed ID: 5108492
    [No Abstract]   [Full Text] [Related]  

  • 11. [Parallelism between nephrocalcitopotropic and estrogenic activity of some anabolic steroids, androgens, progestational hormones and estrogens].
    Pohle K; Bekemeier H
    Endokrinologie; 1968 Feb; 52(5):362-5. PubMed ID: 4302947
    [No Abstract]   [Full Text] [Related]  

  • 12. The differential susceptibility of gonococcal opacity variants to sex hormones.
    Salit IE
    Can J Microbiol; 1982 Mar; 28(3):301-6. PubMed ID: 6805930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of progestogenic substances on the uterine secretion of spayed rats primed with oestradiol.
    Meglioli G; Kalvoda J; Desaulles PA
    Horm Res; 1973; 4(2):97-106. PubMed ID: 4127110
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells.
    Botella J; Duranti E; Viader V; Duc I; Delansorne R; Paris J
    J Steroid Biochem Mol Biol; 1995 Oct; 55(1):77-84. PubMed ID: 7577723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incorporation of tritiated uridine in the genital tract of the eostrogen-treated mouse.
    Miller BG; Emmens CW
    J Endocrinol; 1967 Dec; 39(4):473-84. PubMed ID: 6075192
    [No Abstract]   [Full Text] [Related]  

  • 16. Endocrine activities of some novel steroids.
    McKinney GR; Stavely HE
    Steroids; 1969 Aug; 14(2):91-5. PubMed ID: 5812053
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of steroids on the release of luteinizing hormone in the rat.
    Kobayashi F; Hara K; Miyake T
    Endocrinol Jpn; 1969 Apr; 16(2):251-60. PubMed ID: 5819713
    [No Abstract]   [Full Text] [Related]  

  • 18. Estrogen antagonisms: inhibition of estrone-induced uterine growth by testosterone propionate, progesterone and 17-ethyl-19-nortestosterone.
    EDGREN RA; CALHOUN DW
    Proc Soc Exp Biol Med; 1957 Mar; 94(3):537-9. PubMed ID: 13408318
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-androgen TSAA-291. III. Hormonal spectra of anti-androgen TSAA-291 (16 beta-ethyl-17 beta-hydroxy-4-oestren-3-one) and its derivatives.
    Masuoka M; Masaki T; Yamazaki I; Hori T; Nakayama R
    Acta Endocrinol Suppl (Copenh); 1979; 229():36-52. PubMed ID: 294106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergisms and antagonisms of testosterone: progesterone and estradiol-17-beta:estrone:progesterone mixtures in a uterine bioassay in the mouse.
    Forbes TR
    Endocrinology; 1968 Sep; 83(3):411-3. PubMed ID: 5674018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.